{
    "biomarkers": {
        "oRBB2N93": {
            "name": "DNA methylation patterns",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "DNA methylation patterns",
                "type": "Epigenetic marker",
                "description": "Changes in DNA methylation, an epigenetic mechanism that regulates gene expression without altering the DNA sequence.",
                "findings": "Differential DNA methylation profiles were identified between Circulating Tumor Cells (CTCs) and Colorectal Cancer (CRC) cells, providing insights into their distinct roles and behaviors.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "DNA methylation patterns",
                        "predicate": "differ between",
                        "object": "CTCs and CRC cells"
                    }
                ]
            }
        },
        "ILNL24Pn": {
            "name": "Circulating Tumor Cells (CTCs)",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Circulating Tumor Cells (CTCs)",
                "type": "Cellular marker",
                "description": "Tumor-derived cells that are shed from the primary tumor into the bloodstream, potentially leading to metastasis.",
                "findings": "CTCs in colorectal cancer have distinct methylation profiles compared to CRC cells, indicating unique roles and characteristics.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Circulating Tumor Cells (CTCs)",
                        "predicate": "have",
                        "object": "distinct methylation profiles"
                    }
                ]
            }
        },
        "uz_tKkWt": {
            "name": "Colorectal Cancer (CRC) cells",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Colorectal Cancer (CRC) cells",
                "type": "Cellular marker",
                "description": "Cells originating from colorectal cancer that may exhibit various genetic and epigenetic alterations.",
                "findings": "The study reveals different methylation patterns in CRC cells compared to CTCs, highlighting potential differences in their biology.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Colorectal Cancer (CRC) cells",
                        "predicate": "exhibit",
                        "object": "different methylation patterns"
                    }
                ]
            }
        },
        "QxjxtqEA": {
            "name": "Methylation profiles",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Methylation profiles",
                "type": "Epigenetic marker",
                "description": "Patterns of DNA methylation that can influence gene expression and are often altered in cancer.",
                "findings": "Differential methylation profiles between CTCs and CRC cells provide insights into their distinct biological roles.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Methylation profiles",
                        "predicate": "provide",
                        "object": "insights"
                    }
                ]
            }
        },
        "g_jEbxdd": {
            "name": "Colorectal cancer (CRC)",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Colorectal cancer (CRC)",
                "type": "Disease",
                "description": "A type of cancer that originates in the colon or rectum, characterized by genetic and epigenetic changes.",
                "findings": "The study highlights the distinct roles and characteristics of CTCs in CRC through differential methylation analysis.",
                "notes": "This knowledge is generic to colorectal cancer as described in the article.",
                "knowledge": []
            }
        },
        "2zQ6blRu": {
            "name": "Glycosylated Serum Amyloid A (SAA)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Glycosylated Serum Amyloid A (SAA)",
                "type": "Protein",
                "description": "A serum protein that becomes glycosylated in the presence of inflammation and can be used as a biomarker for inflammatory conditions.",
                "findings": "Glycosylated SAA is elevated in patients with COVID-19 infection, indicating its potential as an acute-phase response marker during viral infections.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Glycosylated Serum Amyloid A (SAA)",
                        "predicate": "is",
                        "object": "elevated in patients with COVID-19 infection"
                    }
                ]
            }
        },
        "gcJg5nxn": {
            "name": "Alpha-1-acid glycoprotein (AGP)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Alpha-1-acid glycoprotein (AGP)",
                "type": "Protein",
                "description": "An acute-phase protein whose levels increase during inflammatory responses and can serve as a biomarker for inflammation.",
                "findings": "Elevated levels of AGP are observed in patients with COVID-19, suggesting its role as an acute-phase response marker.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Alpha-1-acid glycoprotein (AGP)",
                        "predicate": "is",
                        "object": "elevated in patients with COVID-19"
                    }
                ]
            }
        },
        "NWJITul9": {
            "name": "Glycophorin A (GPA)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Glycophorin A (GPA)",
                "type": "Protein",
                "description": "A glycoprotein found on the surface of red blood cells, involved in cell adhesion and serving as a biomarker for inflammation.",
                "findings": "GPA levels are significantly increased in COVID-19 patients compared to healthy controls, indicating its potential as an inflammatory marker.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Glycophorin A (GPA)",
                        "predicate": "is",
                        "object": "significantly increased in COVID-19 patients"
                    }
                ]
            }
        },
        "OxAAlVOv": {
            "name": "Sialylated glycoforms of alpha-1-acid glycoprotein (AGP) and serum amyloid A (SAA)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Sialylated glycoforms of alpha-1-acid glycoprotein (AGP) and serum amyloid A (SAA)",
                "type": "Protein Glycoform",
                "description": "Specific glycosylated forms of proteins associated with inflammatory responses, useful for monitoring inflammation.",
                "findings": "The levels of sialylated glycoforms of AGP and SAA are elevated in COVID-19 patients, highlighting their role as biomarkers for acute-phase response.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Sialylated glycoforms of alpha-1-acid glycoprotein (AGP) and serum amyloid A (SAA)",
                        "predicate": "are",
                        "object": "elevated in COVID-19 patients"
                    }
                ]
            }
        },
        "eHNAC9NV": {
            "name": "Glycosylation patterns",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Glycosylation patterns",
                "type": "Biochemical Marker",
                "description": "Alterations in the glycosylation of serum proteins that can indicate inflammatory states or disease conditions.",
                "findings": "Changes in N-glycan structures and protein glycoform levels are observed during COVID-19 infection, serving as markers for inflammation.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Glycosylation patterns",
                        "predicate": "are altered in",
                        "object": "COVID-19 infection"
                    }
                ]
            }
        },
        "skQM_ojZ": {
            "name": "Generic Inflammatory Biomarker",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Generic Inflammatory Biomarker",
                "type": "Protein",
                "description": "A general marker used to indicate the presence of inflammation, applicable across various inflammatory conditions.",
                "findings": "The study focuses on specific biomarkers for COVID-19 and does not provide findings related to colorectal cancer.",
                "notes": "This is a generic knowledge point as no specific colorectal cancer-related findings are discussed in the article."
            }
        },
        "Gj3z0Alm": {
            "name": "CEx-miRNAs",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "CEx-miRNAs",
                "type": "Biomarker",
                "description": "Exosomal microRNAs (miRNAs) found in circulating extracellular vesicles that are secreted by cells and play roles in intercellular communication.",
                "findings": "CEx-miRNAs, such as miR-126, miR-1290, miR-23a, and miR-940, have shown robust predictive results for early diagnosis and prognosis of colorectal cancer (CRC).",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "CEx-miRNAs",
                        "predicate": "have shown",
                        "object": "robust predictive results"
                    },
                    {
                        "subject": "miR-126, miR-1290, miR-23a, and miR-940",
                        "predicate": "are included in",
                        "object": "CEx-miRNAs panel for CRC diagnosis"
                    }
                ]
            }
        },
        "Ah0_RC5_": {
            "name": "CRISPR/Cas13-based platforms",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "CRISPR/Cas13-based platforms",
                "type": "Diagnostic Method",
                "description": "Emerging molecular diagnostic tools utilizing CRISPR technology, specifically Cas13 enzyme, to detect nucleic acids with high sensitivity and specificity.",
                "findings": "CRISPR/Cas13-based platforms have potential for early next-generation CRC diagnosis due to their ease of use, robustness, scalability, portability, and affordability.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "CRISPR/Cas13-based platforms",
                        "predicate": "have potential for",
                        "object": "early next-generation CRC diagnosis"
                    },
                    {
                        "subject": "CRISPR/Cas13-based platforms",
                        "predicate": "exhibit",
                        "object": "ease of use, robustness, scalability, portability, and affordability"
                    }
                ]
            }
        },
        "kssrBbVG": {
            "name": "CEx-miRNA detection",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "CEx-miRNA detection",
                "type": "Detection Method",
                "description": "Methods used to identify and quantify miRNAs contained within exosomes circulating in body fluids like blood serum.",
                "findings": "Proposed methodologies based on direct CRISPR/Cas13-miRNA detection or SHERLOCK-based miRNA detection aim to enhance CEx-miRNAs detection for early CRC diagnosis.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "CEx-miRNA detection",
                        "predicate": "aims to enhance",
                        "object": "early CRC diagnosis"
                    },
                    {
                        "subject": "Proposed methodologies",
                        "predicate": "are based on",
                        "object": "CRISPR/Cas13-miRNA detection or SHERLOCK-based miRNA detection"
                    }
                ]
            }
        },
        "8MdZm2y1": {
            "name": "MSI-H",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "MSI-H",
                "type": "Genomic Biomarker",
                "description": "Microsatellite instability-high (MSI-H) refers to a condition of genetic hypermutability that results from impaired DNA mismatch repair.",
                "findings": "MSI-H status confers substantial improvements in clinical outcomes and decreased toxicities through ICI, offering patients long-term survival or near curative results.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "MSI-H",
                        "predicate": "confers",
                        "object": "substantial improvements in clinical outcomes"
                    },
                    {
                        "subject": "MSI-H",
                        "predicate": "offers",
                        "object": "patients long-term survival or near curative results"
                    }
                ]
            }
        },
        "qT2su7pq": {
            "name": "RAS",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "RAS",
                "type": "Genomic Biomarker",
                "description": "RAS refers to a family of genes involved in cell signaling pathways that regulate growth and development.",
                "findings": "",
                "notes": "The predictive capacity of RAS necessitates a molecular-targeted approach in CRC.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "necessitates",
                        "object": "molecular-targeted approach in CRC"
                    }
                ]
            }
        },
        "QVcN5eSb": {
            "name": "BRAF V600E",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "BRAF V600E",
                "type": "Genomic Biomarker",
                "description": "BRAF V600E is a mutation in the BRAF gene that leads to constitutive activation of the MAPK/ERK signaling pathway, promoting cancer cell growth.",
                "findings": "BRAF V600E had a negative prognostic value but is now predictive of the response to combined targeted BRAF/EGFR inhibition, doubling survival over standard treatments.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "BRAF V600E",
                        "predicate": "had",
                        "object": "negative prognostic value"
                    },
                    {
                        "subject": "BRAF V600E",
                        "predicate": "is predictive of",
                        "object": "response to combined targeted BRAF/EGFR inhibition"
                    }
                ]
            }
        },
        "Myp9RPIX": {
            "name": "MHC",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "MHC",
                "type": "Immunological Biomarker",
                "description": "Major Histocompatibility Complex (MHC) molecules are cell surface proteins important for the immune system's recognition of foreign molecules.",
                "findings": "",
                "notes": "Dysregulation in expression and function of MHC can impact CRC progression and response to treatment.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "can impact",
                        "object": "CRC progression and response to treatment"
                    }
                ]
            }
        },
        "I7UThxAM": {
            "name": "Tumor Mutational Burden (TMB)",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Tumor Mutational Burden (TMB)",
                "type": "Genomic Biomarker",
                "description": "Tumor mutational burden refers to the number of mutations carried by tumor cells, which can influence the immune system's ability to recognize and attack cancer.",
                "findings": "",
                "notes": "High TMB is associated with better responses to immunotherapy in various cancers.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "is associated with",
                        "object": "better responses to immunotherapy"
                    }
                ]
            }
        },
        "GTCcMBEE": {
            "name": "PD-L1 expression",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "PD-L1 expression",
                "type": "Protein Biomarker",
                "description": "Programmed death-ligand 1 (PD-L1) is a protein that, when expressed on tumor cells, can inhibit T cell function and immune response.",
                "findings": "",
                "notes": "High PD-L1 expression has been linked to increased responsiveness to checkpoint inhibitors in cancer treatment.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "has been linked to",
                        "object": "increased responsiveness to checkpoint inhibitors"
                    }
                ]
            }
        },
        "AIXnxBYK": {
            "name": "HLA Class I expression",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "HLA Class I expression",
                "type": "Immunological Biomarker",
                "description": "Human Leukocyte Antigen (HLA) Class I molecules are essential for presenting peptide antigens to T cells and initiating an immune response.",
                "findings": "",
                "notes": "Reduced HLA Class I expression can help tumor cells evade the immune system.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "can help",
                        "object": "tumor cells evade the immune system"
                    }
                ]
            }
        },
        "QuKiK99v": {
            "name": "MHC-I loss variants",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "MHC-I loss variants",
                "type": "Genomic Biomarker",
                "description": "Loss of heterozygosity in MHC Class I genes can lead to reduced expression on cell surfaces, impacting immune recognition.",
                "findings": "",
                "notes": "These alterations are associated with advanced cancer stages and resistance to therapy.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "are associated with",
                        "object": "advanced cancer stages and resistance to therapy"
                    }
                ]
            }
        },
        "HbNRaWZi": {
            "name": "Infiltrating T cells",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Infiltrating T cells",
                "type": "Immunological Biomarker",
                "description": "The presence of T cells within the tumor microenvironment, often indicative of immune system activity against cancer.",
                "findings": "",
                "notes": "Increased numbers and activity of infiltrating T cells are associated with better outcomes in various cancers.",
                "knowledge": [
                    {
                        "subject": "Generic Knowledge",
                        "predicate": "are associated with",
                        "object": "better outcomes in various cancers"
                    }
                ]
            }
        },
        "gQoh6Psb": {
            "name": "Ki-67",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Ki-67",
                "type": "Cell proliferation marker",
                "description": "Ki-67 is a nuclear protein that is associated with cellular proliferation. It is widely used as a proliferative index to assess the growth fraction of cells in human tumors.",
                "findings": "The study reports decreased Ki-67 expression in treated samples compared to untreated ones, indicating reduced tumor cell proliferation.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Ki-67",
                        "predicate": "decreased",
                        "object": "expression in treated samples"
                    }
                ]
            }
        },
        "nyIYozeU": {
            "name": "Cyclin D1",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Cyclin D1",
                "type": "Cell cycle regulator",
                "description": "Cyclin D1 is a regulatory protein involved in the transition from G1 to S phase of the cell cycle. It plays a critical role in controlling cell proliferation.",
                "findings": "The study observed reduced Cyclin D1 expression following treatment, suggesting impaired progression through the cell cycle.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Cyclin D1",
                        "predicate": "reduced",
                        "object": "expression following treatment"
                    }
                ]
            }
        },
        "mX0OSFeP": {
            "name": "Bcl-2",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Bcl-2",
                "type": "Apoptosis regulator",
                "description": "Bcl-2 is an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. It plays a crucial role in regulating apoptosis by preventing the release of mitochondrial contents.",
                "findings": "The study found decreased Bcl-2 levels in treated samples, indicating increased susceptibility to apoptosis.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Bcl-2",
                        "predicate": "decreased",
                        "object": "levels in treated samples"
                    }
                ]
            }
        },
        "AZn-W3ou": {
            "name": "P53",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "P53",
                "type": "Tumor suppressor protein",
                "description": "P53 is a transcription factor that regulates the cell cycle and functions as a tumor suppressor, preventing cancer formation by repairing DNA or initiating apoptosis.",
                "findings": "Increased P53 expression was noted in treated samples, suggesting enhanced activation of apoptotic pathways.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "P53",
                        "predicate": "increased",
                        "object": "expression in treated samples"
                    }
                ]
            }
        },
        "QvcddhOG": {
            "name": "CD44v6",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "CD44v6",
                "type": "Cell adhesion molecule",
                "description": "CD44v6 is a variant of the CD44 family involved in cell-cell interactions, cell adhesion, and migration. It plays a role in cancer metastasis.",
                "findings": "A reduction in CD44v6 expression was observed following treatment, indicating a potential decrease in metastatic capability.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "CD44v6",
                        "predicate": "reduction",
                        "object": "expression following treatment"
                    }
                ]
            }
        },
        "gOltYeVz": {
            "name": "generic knowledge",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "generic knowledge",
                "type": "generic",
                "description": "Generic knowledge relates to colorectal cancer.",
                "findings": "No specific findings about generic knowledge.",
                "notes": "This is a placeholder for generic knowledge related to colorectal cancer."
            }
        },
        "omdRDFIe": {
            "name": "Guanylate cyclase-C",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Guanylate cyclase-C",
                "type": "Receptor",
                "description": "A receptor involved in signaling pathways that can be relevant for inflammatory conditions and cancer.",
                "findings": "Immunohistochemistry data for Guanylate cyclase-C was performed and interpreted by Guangjian Ma, Innovative Cellular Therapeutics Co.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Guanylate cyclase-C",
                        "predicate": "was performed and interpreted",
                        "object": "immunohistochemistry data"
                    }
                ]
            }
        },
        "MSE3P1pB": {
            "name": "Inflammatory markers",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Inflammatory markers",
                "type": "Biomarkers",
                "description": "Indicators often measured in blood or tissue that can signify inflammation, commonly elevated in various diseases including cancer.",
                "findings": "",
                "notes": "Generic knowledge: Inflammation is associated with colorectal cancer progression and risk."
            }
        },
        "-x17maW_": {
            "name": "Chimeric Antigen Receptor (CAR)",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Chimeric Antigen Receptor (CAR)",
                "type": "Molecular Therapy",
                "description": "A genetically engineered receptor that enables T cells to recognize and attack cancer cells more effectively.",
                "findings": "Quality control and testing of the CAR product were conducted by Wenli Li, ME, Shiquan Lv, BS, Gaopeng Xu, BS, and Nengkai Cen, ME, Innovative Cellular Therapeutics Co.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Chimeric Antigen Receptor (CAR)",
                        "predicate": "quality control and testing conducted",
                        "object": "by Wenli Li, Shiquan Lv, Gaopeng Xu, Nengkai Cen"
                    }
                ]
            }
        },
        "vOKRtAEr": {
            "name": "hCRISPRs",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "hCRISPRs",
                "type": "molecular biomarkers",
                "description": "Human CRISPR-associated repeats are sequences derived from viral defense mechanisms found in the human genome that may play roles in gene regulation.",
                "findings": "The study designed research questions to detect and validate hCRISPRs' role in transcription and diagnostics, specifically for cancer diagnosis.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "hCRISPRs",
                        "predicate": "designed research questions to detect and validate",
                        "object": "role in transcription and diagnostics"
                    }
                ]
            }
        },
        "XIvrtuOC": {
            "name": "SHERLOCK",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "SHERLOCK",
                "type": "diagnostic technology",
                "description": "SHERLOCK is a CRISPR-based diagnostic platform used for detecting nucleic acids with high sensitivity.",
                "findings": "The study involved testing, optimizing, and running SHERLOCK for potential applications in cancer diagnostics.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "SHERLOCK",
                        "predicate": "tested, optimized, and run",
                        "object": "for potential applications in cancer diagnostics"
                    }
                ]
            }
        },
        "7N89DpJS": {
            "name": "DETECTR",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "DETECTR",
                "type": "diagnostic technology",
                "description": "DETECTR is a CRISPR-based diagnostic platform for identifying specific genetic sequences with high precision.",
                "findings": "The study tested, optimized, and ran DETECTR as part of efforts to utilize CRISPR technologies in cancer diagnostics.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "DETECTR",
                        "predicate": "tested, optimized, and run",
                        "object": "as part of efforts to utilize in cancer diagnostics"
                    }
                ]
            }
        },
        "rERv2YiW": {
            "name": "MiTranscriptome datasets",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "MiTranscriptome datasets",
                "type": "biomarker data source",
                "description": "The MiTranscriptome dataset includes comprehensive information on human RNA transcripts, used for validating biomarkers.",
                "findings": "Analysis and organization of the MiTranscriptome datasets were performed to support research into hCRISPRs and their diagnostic potential.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "MiTranscriptome datasets",
                        "predicate": "analyzed and organized",
                        "object": "to support research into hCRISPRs"
                    }
                ]
            }
        },
        "FNj_zceD": {
            "name": "generic colorectal cancer biomarkers",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "generic colorectal cancer biomarkers",
                "type": "biomarker type (general)",
                "description": "General markers associated with the detection or risk assessment of colorectal cancer, potentially including genetic mutations or protein expressions.",
                "findings": "",
                "notes": "This entry contains generic knowledge about colorectal cancer as no specific findings were reported in this article."
            }
        },
        "BCj4QBSI": {
            "name": "acetone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "acetone",
                "type": "volatile organic compound (VOC)",
                "description": "Acetone is a simple ketone that is commonly found in the breath and can be indicative of metabolic processes.",
                "findings": "Acetone concentration in breath changes during activities such as exercising or fasting, limiting its use as an adequate biomarker for cancer diagnosis.",
                "notes": "The acetone concentration is influenced by physical activities like exercising or fasting, making it unsuitable solely as a cancer biomarker.",
                "knowledge": [
                    {
                        "subject": "acetone",
                        "predicate": "changes during",
                        "object": "activities such as exercising or fasting"
                    }
                ]
            }
        },
        "LMLX5vAv": {
            "name": "4-heptanone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "4-heptanone",
                "type": "volatile organic compound (VOC)",
                "description": "4-Heptanone is a ketone that can be emitted in exhaled breath and has been studied for its potential as a biomarker.",
                "findings": "The origins of 4-heptanone are unclear, which limits its recommendation for use as a cancer biomarker.",
                "notes": "Due to the unclear origins, it is not recommended as a reliable biomarker for cancer diagnosis.",
                "knowledge": [
                    {
                        "subject": "4-heptanone",
                        "predicate": "origins of are unclear",
                        "object": "not recommended for use as biomarkers"
                    }
                ]
            }
        },
        "vkjICGVv": {
            "name": "volatile organic compounds (VOCs)",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "volatile organic compounds (VOCs)",
                "type": "group of biomarkers",
                "description": "Volatile organic compounds are a broad category of chemicals that can be found in exhaled breath and are studied for their potential to indicate various health conditions.",
                "findings": "Analyzing big data with advanced instruments might help solve the problem of VOCs related to gastric and colorectal cancer.",
                "notes": "This research is still ongoing, and further studies are required to validate the use of VOCs as biomarkers for GI cancers."
            }
        },
        "1e-RdMMW": {
            "name": "Microbiome composition",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Microbiome composition",
                "type": "Biomarker",
                "description": "Refers to the specific types and quantities of microorganisms present in a particular environment within the human body.",
                "findings": "The study analyzed microbiome data to identify biomarkers related to colorectal cancer risk using XAI methods.",
                "notes": "Publicly available datasets were used for analysis, providing insights into microbiome composition as potential biomarkers.",
                "knowledge": [
                    {
                        "subject": "Microbiome composition",
                        "predicate": "analyzed",
                        "object": "to identify biomarkers related to colorectal cancer risk"
                    }
                ]
            }
        },
        "Xw6Xvl6U": {
            "name": "Inflammation markers in microbiome data",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Inflammation markers in microbiome data",
                "type": "Biomarker",
                "description": "Markers indicating the presence of inflammation within the gut, which can be linked to colorectal cancer development.",
                "findings": "The study discusses the role of inflammation markers identified through microbiome analysis in relation to cancer diagnosis.",
                "notes": "Inflammation is a critical factor considered in the context of colorectal cancer risk assessment.",
                "knowledge": [
                    {
                        "subject": "Inflammation markers in microbiome data",
                        "predicate": "discussed",
                        "object": "in relation to cancer diagnosis"
                    }
                ]
            }
        },
        "_czjsna5": {
            "name": "General colorectal cancer biomarkers",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "General colorectal cancer biomarkers",
                "type": "Biomarker",
                "description": "Molecular or cellular indicators used for the detection, risk assessment, and monitoring of colorectal cancer.",
                "findings": "The article generically relates to colorectal cancer without specific findings on novel biomarkers.",
                "notes": "Generic knowledge about colorectal cancer is provided as no specific new findings are discussed in the article."
            }
        },
        "tLEAQm16": {
            "name": "Breath-print",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Breath-print",
                "type": "Biomarker",
                "description": "A unique pattern of volatile organic compounds (VOCs) found in the breath that can indicate various health conditions.",
                "findings": "The study demonstrated a distinct breath-print for CRC patients, showing high accuracy in discrimination from controls.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Breath-print",
                        "predicate": "demonstrated",
                        "object": "distinct pattern for CRC patients"
                    },
                    {
                        "subject": "Breath-print",
                        "predicate": "showed",
                        "object": "high accuracy in discrimination from controls"
                    }
                ]
            }
        },
        "KBhXlp6q": {
            "name": "Volatile Organic Compounds (VOCs)",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Volatile Organic Compounds (VOCs)",
                "type": "Biomarkers",
                "description": "Chemical compounds that are emitted as gases from various biological processes and can be used for diagnostic purposes.",
                "findings": "The study identified different VOCs in CRC patients, suggesting their potential role in colorectal cancer diagnosis.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Volatile Organic Compounds (VOCs)",
                        "predicate": "identified",
                        "object": "different compounds in CRC patients"
                    },
                    {
                        "subject": "Volatile Organic Compounds (VOCs)",
                        "predicate": "suggesting",
                        "object": "potential role in colorectal cancer diagnosis"
                    }
                ]
            }
        },
        "s4-WGm6l": {
            "name": "Alkenes, Alcohols, Ketones, Esters",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Alkenes, Alcohols, Ketones, Esters",
                "type": "Biomarkers",
                "description": "Specific types of VOCs that may be present in exhaled breath and are associated with various metabolic processes.",
                "findings": "These compounds were discussed as potential biomarkers for CRC due to their biochemical roles and presence in breath samples.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Alkenes, Alcohols, Ketones, Esters",
                        "predicate": "discussed",
                        "object": "potential biomarkers for CRC"
                    }
                ]
            }
        },
        "vvJrVAKK": {
            "name": "Reactive Oxygen Species (ROS) and Free Radicals",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Reactive Oxygen Species (ROS) and Free Radicals",
                "type": "Biomarker",
                "description": "Chemical species that can cause oxidative stress, potentially leading to cellular damage and cancer.",
                "findings": "The study mentions the role of ROS and free radicals in affecting hydrocarbon emission in breath samples.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Reactive Oxygen Species (ROS) and Free Radicals",
                        "predicate": "affects",
                        "object": "hydrocarbon emission in breath samples"
                    }
                ]
            }
        },
        "r5sHFBQC": {
            "name": "General Biomarker Knowledge for CRC",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "General Biomarker Knowledge for CRC",
                "type": "Generic Information",
                "description": "Non-specific information related to biomarkers and their application in colorectal cancer.",
                "findings": "",
                "notes": "This is generic knowledge only.",
                "knowledge": []
            }
        },
        "yypdy1n_": {
            "name": "T-antigen",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "T-antigen",
                "type": "Glycan Biomarker",
                "description": "A truncated form of the blood group H antigen that can be expressed aberrantly in cancer cells.",
                "findings": "Stools from more aggressive lesions exhibited abnormal immature glycan signatures, including T-antigen, not seen in healthy tissues.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "T-antigen",
                        "predicate": "exhibited",
                        "object": "abnormal immature glycan signatures"
                    },
                    {
                        "subject": "T-antigen",
                        "predicate": "associated with",
                        "object": "more aggressive lesions"
                    }
                ]
            }
        },
        "ncLJrlgl": {
            "name": "FIT (Fecal Immunochemical Test)",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "FIT (Fecal Immunochemical Test)",
                "type": "Cancer Screening Biomarker",
                "description": "A test that detects hidden blood in the stool, often used as a screening tool for colorectal cancer.",
                "findings": "The analysis of patients with negative FIT results is required to fully disclose the potential of these biomarkers for non-invasive CRC screening.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "FIT",
                        "predicate": "requires",
                        "object": "analysis of patients with negative results"
                    }
                ]
            }
        },
        "_4ttS6r9": {
            "name": "Stool Glycoproteome",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Stool Glycoproteome",
                "type": "Glycan Biomarker Profile",
                "description": "The complete set of glycoproteins present in stool, providing insights into disease-related changes.",
                "findings": "Characterization of the stool glycoproteome identified several molecular targets shared by more aggressive non-cancerous lesions and cancer.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Stool Glycoproteome",
                        "predicate": "characterized",
                        "object": "molecular targets shared by aggressive lesions"
                    }
                ]
            }
        },
        "KZFd01-T": {
            "name": "Colorectal Cancer Glycode",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Colorectal Cancer Glycode",
                "type": "Glycan Biomarker Profile",
                "description": "The pattern of glycosylation alterations associated with colorectal cancer.",
                "findings": "This work showcases the unexplored potential of the CRC glycocode for non-invasive disease detection.",
                "notes": "",
                "knowledge": [
                    {
                        "subject": "Colorectal Cancer Glycode",
                        "predicate": "showcases",
                        "object": "potential for non-invasive disease detection"
                    }
                ]
            }
        },
        "Vwey0UaR": {
            "name": "Generic Biomarker Knowledge",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/ZfOe_",
            "details": {
                "name": "Generic Biomarker Knowledge",
                "type": "General",
                "description": "",
                "findings": "Provides a framework for addressing potential relevant alterations in glycosylation related to colorectal cancer.",
                "notes": "This is generic knowledge about colorectal cancer and its potential biomarkers.",
                "knowledge": []
            }
        }
    },
    "documents": {
        "10.1038/s41598-023-42037-w": {
            "doi": "10.1038/s41598-023-42037-w",
            "short_citation": "(Bao-Caamano;2023)",
            "long_citation": "Bao-Caamano, et al., Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer, , 2023"
        },
        "10.1002/anie.202306154": {
            "doi": "10.1002/anie.202306154",
            "short_citation": "(Saraei;2019)",
            "long_citation": "Saraei, et al., Towards a Precise NMR Quantification of Acute Phase Inflammation Proteins from Human Serum, , 2019"
        },
        "10.3390/cancers13184640": {
            "doi": "10.3390/cancers13184640",
            "short_citation": "(Dur\u00e1n-Vin;2021-09-16)",
            "long_citation": "Dur\u00e1n-Vin, et al., CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review, , 2021-09-16"
        },
        "10.3390/cancers16162796": {
            "doi": "10.3390/cancers16162796",
            "short_citation": "(Ashouri;2024-08-08)",
            "long_citation": "Ashouri, et al., Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review, , 2024-08-08"
        },
        "10.1126/sciadv.aaw1317": {
            "doi": "10.1126/sciadv.aaw1317",
            "short_citation": "(Carvalho;2024-12-04)",
            "long_citation": "Carvalho, et al., Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine, , 2024-12-04"
        },
        "10.1001/jamaoncol.2024.3891": {
            "doi": "10.1001/jamaoncol.2024.3891",
            "short_citation": "(Chen;2024-09-19)",
            "long_citation": "Chen, et al., Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer A Nonrandomized Clinical Trial, , 2024-09-19"
        },
        "10.1038/s42003-022-03249-4": {
            "doi": "10.1038/s42003-022-03249-4",
            "short_citation": "(Van Riet;1989)",
            "long_citation": "Van Riet, et al., CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue, , 1989"
        },
        "10.3390/ijms24010129": {
            "doi": "10.3390/ijms24010129",
            "short_citation": "(Chen;2022-12-21)",
            "long_citation": "Chen, et al., Diagnosis by Volatile Organic Compounds in Exhaled Breath from Patients with Gastric and Colorectal Cancers, , 2022-12-21"
        },
        "10.1111/j.2517-6161.1982.tb01195.x": {
            "doi": "10.1111/j.2517-6161.1982.tb01195.x",
            "short_citation": "(D'elia;1982)",
            "long_citation": "D'elia, et al., Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification, , 1982"
        },
        "10.1002/ijc.29701": {
            "doi": "10.1002/ijc.29701",
            "short_citation": "(Amal;2015)",
            "long_citation": "Amal, et al., Breath testing as potential colorectal cancer screening tool, , 2015"
        },
        "10.3390/ijms25073722": {
            "doi": "10.3390/ijms25073722",
            "short_citation": "(Kuppen;2024-03-27)",
            "long_citation": "Kuppen, et al., Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer, , 2024-03-27"
        }
    },
    "lang_info": {
        "phi4:14b/ZfOe_": {
            "llm_tag": "phi4:14b",
            "prompt_template": "[BEGIN ARTICLE]:<content></content>\n[END ARTICLE]\n\n[INSTRUCTIONS]\nGenerate list of biomarkers that are mentioned as methods, result or discussion in the article and relates to disease, inflamation or specifically cancer diagnosis or risc. \nList only biomarkers that some findings are in the article. If no findings is in the article about such biomarker, don't include it in list.\nFor each such biomarker extract name, type, description, notes and findings.\nFor findings, put the findings about the biomarker that are either result or discussed in the article.\nFor description, put general description of the biomarker, that description do not need to be in the article but should be descriptive.\nFor notes, put general notes about biomarker that are explicitly noted in the article besides findings. \nFor each finding generate a formal knowledge triplet separated to \"subject\",\"predicate\",\"object\" where \"subject\" is biomarker, \"predicate\" is verb from finding and \"object\" is an object from the finding.\nIf there is no knowledge in the article, generate single generic knowledge that relates to colorectal cancer and leave in the notes that it is generic knowledge only.\nReturn the response in strict JSON format with the following structure:\n\n[\n  { \"name\": \"biomarker name\",\"type\":\"biomarker type\",\"description\":\"biomarker description\",\"findings\":\"brief findings about biomarker in article as one sentence\",\"notes\":\"additional notes important to biomarker or empty string\", \"knowledge\":[{\"subject\":\"repeated biomarker name\",\"predicate\":\"some predicate from findings of biomarker\",\"object\":\"object that relates via predicate to the biomarker\" }],\n  { \"name\": \"biomarker2 name\",\"type\":\"biomarker2 type\",\"description\":\"biomarker2 description\",\"findings\":\"brief findings about biomarker2 in article as one sentence\",\"notes\":\"additional notes important to biomarker2 or empty string\", \"knowledge\":[{\"subject\":\"repeated biomarker2 name\",\"predicate\":\"some predicate from findings of  biomarker2\",\"object\":\"object that relates via predicate to the biomarker2\" }] }\n] \n\nEnsure there is no additional explanation, only return valid JSON.\n"
        }
    }
}